Endothelial dysfunction in patients with antiphospholipid syndrome assessed with positron emission tomography

Journal of Nuclear Cardiology

Volumn 14, Issue 4 SPEC. ISS., 2007, Pages 566-572

  Alexanderson, Erick ^a,b   Cruz, Patricio ^a   Vargas, Angélica ^a   Meave, Aloha ^a   Ricalde, Alejandro ^b   Talayero, Jose A ^b   Romero Ibarra, José Luis ^b   Goldson, Tovë M ^b   Vera Lastra, Olga L ^c   Medina, Gabriela ^c   Jara, Luis ^c   Amigo, Mary Carmen ^a  

^a INSTITUTO NACIONAL DE CARDIOLOGÍA IGNACIO CHÁVEZ   (Mexico)

^b UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

^c INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

Author keywords

Antiphospholipid syndrome; endothelial dysfunction; myocardial blood flow; positron emission tomography

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE; AMLODIPINE; AMMONIA N 13; ANTICOAGULANT AGENT; ANTIMALARIAL AGENT; CAPTOPRIL; NONSTEROID ANTIINFLAMMATORY AGENT; STEROID;

ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CLINICAL ARTICLE; COLD PRESSOR TEST; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; HEART MUSCLE BLOOD FLOW; HUMAN; HYPERTENSION; LOW DRUG DOSE; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 34547471144     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nuclcard.2007.05.003     Document Type: Article

References (45)

1. Amengual O., Atsumi T., and Khamashta A. Tissue factor in antiphospholipid syndrome: shifting the focus from coagulation to endothelium. Rheumatology (Oxford) 42 (2003) 1029-1031
2. Meroni P.L., Raschi E., Testoni C., Tincani A., and Balestrieri G. Antiphospholipid antibodies and the endothelium. Rheum Dis Clin North Am 27 (2001) 587-602
3. Khamashta M. Anticardiolipin test and the antiphospholipid (Hughes) syndrome: 20 years and counting!. J Rheumatol 31 (2004) 2099-2101
4. Del Río García E., Rodríguez C., Rodríguez-Martorell J., Serrano A., and Giron-González J.A. Platelet and endothelial activation are requisites for the development of antiphospholipid syndrome. Ann Rheum Dis 63 (2004) 600-601
5. Pierangeli S.S., Vega-Ostertag M., and Harris E.N. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. Thromb Res 114 (2004) 467-476
6. Luscher T.F., and Barton M. Biology of the endothelium. Clin Cardiol 20 Suppl 2 (1997) 3-10
7. González Chávez A., Rosas Carrasco O., and Alexánderson Rosas G. Disfunción endotelial y síndrome metabólico. In: Gonzalez, Lavalle, and Rios (Eds). Síndrome metabólico y enfermedad cardiovascular (2004), Editorial Intersistemas, México City 87-129
8. Furchgott R.F., and Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288 (1980) 373-376
9. Zeiher A.M., Drexler H., Wollschlaeger H., Saurbier B., and Just H. Coronary vasomotion in response to sympathetic stimulation in humans: importance of the functional integrity of the endothelium. J Am Coll Cardiol 14 (1989) 1181-1190
10. Verma S., and Anderson T. Fundamentals of endothelial function for clinical cardiologists. Circulation 105 (2002) 546-549
11. Campisi R., and Di Carli M. Assessment of coronary flow reserve and microcirculation: a clinical perspective. J Nucl Cardiol 11 (2004) 3-11
12. Muzik O., Beanlands R.S., Hutchins G.D., Manger T.J., Nguyen N., and Schwaiger M. Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET. J Nucl Med 34 (1993) 83-91
13. Zeiher A.M., Drexler H., Wollschlager H., and Just H. Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis. Circulation 84 (1991) 1984-1992
14. Di Carli M.F., Janisse J., Grunberger G., and Ager J. Role of chronic hyperglycemia in the pathogenesis of coronary microvascular dysfunction in diabetes. J Am Coll Cardiol 41 (2003) 1387-1393
15. Di Carli M.F., Dorbala S., Hassan A., et al. Relation of coronary vasodilator reserve to features of the metabolic syndrome in patients with documented or at risk for coronary artery disease. Circulation 108 Suppl IV (2003) 404
16. Hamasaki S., Al Suwaidi J., Higano S.T., Miyauchi K., Holmes Jr. D.R., and Lerman A. Attenuated coronary flow reserve and vascular remodeling in patients with hypertension and left ventricular hypertrophy. J Am Coll Cardiol 35 (2000) 1654-1660
17. Panza J.A., Quyyumi A.A., Brush Jr. J.E., and Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 323 (1990) 22-27
18. Treasure C.B., Klein J.L., Vita J.A., Manoukian S.V., Renwick G.H., Selwyn A.P., et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation 87 (1993) 86-93
19. Houghton J.L., Frank M.J., Carr A.A., von Dohlen T.W., and Prisant L.M. Relations among impaired coronary artery disease. J Am Coll Cardiol 15 (1990) 43-51
20. Akinoboboye O.O., Chou R.L., and Bergmann S.R. Augmentation of myocardial blood flow in hypertensive heart disease by angiotensin antagonists: a comparison of lisinopril and losartan. J Am Coll Cardiol 40 (2002) 702-709
21. Laine H., Raitakari O.T., Niinikoski H., Pitkanen O.P., Iida H., Viikari J., et al. Early impairment of coronary flow reserve in young men with borderline hypertension. J Am Coll Cardiol 32 (1998) 147-153
22. Czernin J., Sun K., Brunken R., Bottcher M., Phelps M., and Schelbert H. Effect of acute and long-term smoking on myocardial blood flow reserve. Circulation 91 (1995) 2891-2897
23. Kaufmann P.A., Gnecchi-Ruscone T., di Terlizzi M., Schafers K.P., Luscher T.F., and Camici P.G. Coronary heart disease in smokers: vitamin C restores coronary microcirculatory function. Circulation 102 (2000) 1233-1238
24. Campisi R., Czemin J., Schoder H., Sayre J.W., Marengo F.D., Phelps M.E., et al. Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity. Circulation 98 (1998) 119-125
25. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311
26. Wienhard K., Dahlbom M., Eriksson L., Michel C., Bruckbauer T., Pietrzyk U., et al. The ECAT EXACT HR: performance of a new high resolution positron scanner. J Comput Assist Tomogr 18 (1994) 110-118
27. 15O]water techniques. Circulation 93 (1996) 2000-2006
28. 13N]ammonia and reoriented dynamic positron emission tomographic imaging. Circulation 86 (1992) 1004-1017
29. Schindler T.H., Nitzsche E., Olschewski M., Brink I., Mix M., Prior J., et al. PET-measured responses of MBF to cold pressor testing correlate with indices of coronary vasomotion on quantitative coronary angiography. J Nucl Med 45 (2004) 419-428
30. Schindler T.H., Nitzsche E.U., Schelbert H.R., Olschewski M., Sayre J., Mix M., et al. Positron emission tomography-measured abnormal responses of myocardial blood flow to sympathetic stimulation are associated with the risk of developing cardiovascular events. J Am Coll Cardiol 45 (2005) 1505-1512
31. Kichuk M.R., Seyedi N., Zhang X., Marboe C.C., Michler R.E., Addonizio L.J., et al. Regulation of nitric oxide production in human coronary microvessels and the contribution of local kinin formation. Circulation 94 (1996) 44-51
32. Nabel E.G., Ganz P., Gordon J.B., Alexander R.W., and Selwyn A.P. Dilation of normal and constriction of atherosclerotic coronary arteries caused by the cold pressor test. Circulation 77 (1988) 43-52
33. Alam T.A., Seifalian A.M., and Baker D. A review of methods currently used for assessment of in vivo endothelial function. Eur J Vasc Endovasc Surg 29 (2005) 269-276
34. Deanfield J., Donald A., Ferri C., Giannattasio C., Halcox J., Halligan S., et al. Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens 23 (2005) 7-17
35. Vlachoyiannopoulos P.G., Kanellopoulos P.G., Ioannidis J.P., Tektonidou M.G., Mastorakou I., and Moutsopoulos H.M. Atherosclerosis in premenopausal women with antiphospholipid syndrome and systemic lupus erythematosus: a controlled study. Rheumatology (Oxford) 42 (2003) 645-651
36. Medina G., Casaos D., Jara L.J., Vera-Lastra O., Fuentes M., Barile L., et al. Increased carotid artery intima-media thickness may be associated with stroke in primary antiphospholipid syndrome. Ann Rheum Dis 62 (2003) 607-610
37. Ames P.R., Margarita A., Sokoll K.B., Weston M., and Brancaccio V. Premature atherosclerosis in primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis 64 (2005) 315-317
38. Jimenez S., García-Criado A., Tàssies D., Reverter J.C., Cervera R., Gilabert M.R., et al. Preclinical vascular disease in systemic lupus erythematosus and primary antiphospholipid syndrome. Rheumatology (Oxford) 44 (2005) 756-761
39. Widlansky M., Gokce N., Keaney J., and Vita J. The clinical implications of endothelial dysfunction. J Am Coll Cardiol 42 (2003) 1149-1160
40. Faulx M., Wright A.T., and Hoit B.D. Detection of endothelial dysfunction with brachial artery ultrasound scanning. Am Heart J 145 (2003) 943-951
41. Baron M.A., Khamashta M.A., Hughes G.R.V., and D'Cruz D.P. Prevalence of an abnormal ankle-brachial index in patients with primary antiphospholipid syndrome: preliminary data. Ann Rheum Dis 64 (2005) 144-146
42. Mercanoglu F., Erdogan D., Oflaz H., Kucukkaya R., Selcukbiricik F., Gul A., et al. Impaired brachial endothelial function in patients with primary antiphospholipid syndrome. Int J Clin Pract 58 (2004) 1003-1007
43. Buus N.H., Hermansen F., Sander M., Nielsen T.T., and Mulvany M.J. Influence of nitric oxide synthase and adrenergic inhibition on adenosine-induced myocardial hyperemia. Circulation 104 (2001) 2305-2310
44. Alexanderson E., Romero J.L., Ricalde A., Alexanderson G., and Meave A. Assessment of endothelial function by positron emission tomography. Curr Cardiol Rev 2 (2006) 101-107
45. Kjaer A., Meyer C., Nielsen F.S., Parving H.H., and Hesse B. Dipyridamole, cold pressor test, and demonstration of endothelial dysfunction: a PET study of myocardial perfusion in diabetes. J Nucl Med 44 (2003) 19-23